Drug intelligence / Profile preview

d-[(n-hydroxyamino)carbonyl]phenylalanine

Development stage: Unknown
Modality: Small Molecules

Overview

D-[(N-Hydroxyamino)Carbonyl]Phenylalanine is a synthetic, non-proteinogenic amino acid derivative belonging to the class of phenylalanine and its derivatives. It has the molecular formula C10H12N2O4 and a molecular weight of 224.21 g/mol[1][2][3][4][5][9][10]. The compound is classified as a small molecule and has been studied primarily in experimental settings, with no approved medical indications or clinical trial activity beyond preclinical research[1]. Its potential therapeutic applications are not well characterized in public sources, and there is no detailed information available regarding its mechanism of action or specific biological targets[1][2][4].

Other names: D-[(N-Hydroxyamino)Carbonyl]PhenylalanineINF

Targets

CPA1 (Carboxypeptidase A1)

Beyond the preview

Go deeper on d-[(n-hydroxyamino)carbonyl]phenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-[(n-hydroxyamino)carbonyl]phenylalanine.

Explore the full profile